Women in Heart Transplantation and MCS
@Womenintxp_mcs
We hope to support and empower each other to enhance professional and personal success for women in the field of MCS and heart transplantation.
We’re thrilled to announce the launch of our new international tiered membership pricing! Making it easier than ever to join our global community of trailblazers to connect, grow, and lead. 👉 nam04.safelinks.protection.outlook.com/?url=https%3A%…
Meet Yuri Kim! Dr. Kim is one of the two first awardees of the Heart Failure Research Foundation’s Emerging Leader Grants. Dr. Kim’s research is focused on pinpointing how cancer treatments affect the heart, becoming better at identifying patients at risk, and developing improved…
No better choice than @shelleyhallmd!
Incredibly proud of @shelleyhallmd for representing the transplant community as a newly elected member of the inaugural #OPTN Board of Directors. A true leader shaping the future of organ transplantation. 👏🫀 #TransplantLeadership #OrganDonation
Incredibly proud of @shelleyhallmd for representing the transplant community as a newly elected member of the inaugural #OPTN Board of Directors. A true leader shaping the future of organ transplantation. 👏🫀 #TransplantLeadership #OrganDonation
DCD donors are being increasingly used for #HT. But are they being used equitably? We sought to look at utilization and outcomes of DCD HT between 🚹 and 🚺 in the UNOS registry now published in @CircHF. ahajournals.org/doi/10.1161/CI… 🧵to follow
Shout out and many congratulations to @EMDeFilippisMD @DhariniRamu @rcogswell_umn @elenamdonald and team for this important work 👏
Sex Differences in Utilization of Donation After Circulatory Death Donors for Heart Transplantation and Associated Outcomes @NirUrielMD @ersied727 @DhariniRamu @elenamdonald @rcogswell_umn #AHAJournals ahajrnls.org/3I12ugh
@BiykemB leading the way 👏🏼👏🏼👏🏼
Our tips & tricks for scientific writing & publishing high-quality manuscripts #3CT With Stuart Spencer, Biykem Bozkurt, Michael Harhay..
A true honor to be a part of the Assisted Circulation #GRC2025. Thank you to the GRC chairs for the opportunity to share our work and springboard collaborations with clinicians and engineers in #MCS.
Today at Assisted Circulation #GRC @GordonConf in Barcelona: #TuftsMedicine's @KayEverettMDPhD presents Ventricular and Vascular Biomechanics of VA-ECMO. ⏱️ 9:55–10:10 am (Local time) #ECMO #CardioTwitter #MCS
Turning wearable data into tomorrow’s heart failure prognosis —welcome to the future of care. @UHN @Apple @Womenintxp_mcs @UofT_TCAIREM @GLewisCardiol @ISHLT @EricTopol @HFSA @ACTION4HF @hfcollaboratory
Developments in Digital Wearable in Heart Failure and the Rationale for the Design of TRUE-HF (Ted Rogers Understanding of Exacerbations in Heart Failure) Apple CPET Study @faridftn @yasmoayedi @Doctor_Darshan @transformhf @CmcintoshAi @hearthealthydoc ahajrnls.org/45d0kUg
Great to see this paper out in @JACCJournals Establishing the role of transthyretin (prealbumin) as a surrogate of treatment effect of transthyretin stabilizers in ATTR-CM, such as acoramidis in this particular paper jacc.org/doi/epdf/10.10… #CardioTwitter
🥳 to my amazing co-authors @Womenintxp_mcs for👇 ❤️ working with this INCREDIBLE collaborative group of 💃🏽 ✍️ Have research 💡? Want to get involved? Seeking community? 📞 #HF docs/fellows!! Join the WiTMCS Research Group meeting THIS week 5/21 @ 4 PM EST!
📣🔥Read our ‘Practical Guide on Induction Immunosuppression in 🫀 #Transplant led by the brilliant #AndrianaNikolava 🏷️Limited data in standard-risk #HT pts 🏷️Induction safe in LVAD, efficacy unclear 🏷️rATG > IL2RA for high-risk 🎯Need for prospective, mechanistic studies
📣🔥Read our ‘Practical Guide on Induction Immunosuppression in 🫀 #Transplant led by the brilliant #AndrianaNikolava 🏷️Limited data in standard-risk #HT pts 🏷️Induction safe in LVAD, efficacy unclear 🏷️rATG > IL2RA for high-risk 🎯Need for prospective, mechanistic studies
Incredibly proud of our team for our donor utilization initiative. jacc.org/doi/10.1016/j.… Happy to share templates, report add and dashboard code. 🙏🏽vanguard speakers @UHNTransplant @ISHLT @JACCJournals @trogersresearch @KiranKhush1 @CandiceSilvers1 @MaryjaneFarrMD
Last reminder on this happening TONIGHT 👇🏽 Come join like-minded clinicians and scientists for a robust discussion on advancing HF care for 🙋🏻♀️🙋🏽♀️🙋♀️ ⏱️7pm Central 📍Virtual, link : us06web.zoom.us/j/85014839280?… @Womenintxp_mcs @AbbottNews
Why Are Women Still Being Left Behind in Heart Failure Care? Join us Monday, May 12th at 7:00 PM CST for the first session of the WiTMCS #AHF Therapies in Women Webinar Series @CindyMMartinMD @Dr_Eileen_Hsich #SharonBethLarson @AditiNayakMD
Why Are Women Still Being Left Behind in Heart Failure Care? Join us Monday, May 12th at 7:00 PM CST for the first session of the WiTMCS #AHF Therapies in Women Webinar Series @CindyMMartinMD @Dr_Eileen_Hsich #SharonBethLarson @AditiNayakMD
🚨We're Hiring! @HopkinsHeart Umapathi Lab @HopkinsMedicine seeking a senior post-doc (1 yr, fully funded) to lead cutting-edge, translational research in cardiac iPSC, metabolism, O-GlcNAc & heart failure 🔬 Apply now! 🙏Re-Post😊 #CardioResearch #PostdocJobs #HeartFailure
🚨Hiring! @hopkinsheart |Umapathi Lab @HopkinsMedicine 👀For PhD/post-doc ASAP for lab-based (fully funded) 1-year position leading basic-translational🫀research 🔋Cardiac metabolism 🧬Inherited cardiomyopathy 🟦Cardiac O-GlcNAc biology 🧫iPSC development 🙏 re-post🙏apply!